Is Zimmer Biomet (ZBH) Stock Undervalued Right Now?
Werte in diesem Artikel
The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always looking at the latest trends in value, growth, and momentum to find strong picks.Of these, perhaps no stock market trend is more popular than value investing, which is a strategy that has proven to be successful in all sorts of market environments. Value investors use fundamental analysis and traditional valuation metrics to find stocks that they believe are being undervalued by the market at large.Zacks has developed the innovative Style Scores system to highlight stocks with specific traits. For example, value investors will be interested in stocks with great grades in the "Value" category. When paired with a high Zacks Rank, "A" grades in the Value category are among the strongest value stocks on the market today.One company value investors might notice is Zimmer Biomet (ZBH). ZBH is currently sporting a Zacks Rank #2 (Buy), as well as a Value grade of A. The stock holds a P/E ratio of 12.09, while its industry has an average P/E of 21.19. Over the past 52 weeks, ZBH's Forward P/E has been as high as 13.52 and as low as 10.73, with a median of 12.37.Finally, our model also underscores that ZBH has a P/CF ratio of 10.74. This metric takes into account a company's operating cash flow and can be used to find stocks that are undervalued based on their solid cash outlook. ZBH's P/CF compares to its industry's average P/CF of 12.09. Over the past year, ZBH's P/CF has been as high as 11.88 and as low as 9.36, with a median of 10.66.These are just a handful of the figures considered in Zimmer Biomet's great Value grade. Still, they help show that the stock is likely being undervalued at the moment. Add this to the strength of its earnings outlook, and we can clearly see that ZBH is an impressive value stock right now.Radical New Technology Could Hand Investors Huge GainsQuantum Computing is the next technological revolution, and it could be even more advanced than AI.While some believed the technology was years away, it is already present and moving fast. Large hyperscalers, such as Microsoft, Google, Amazon, Oracle, and even Meta and Tesla, are scrambling to integrate quantum computing into their infrastructure.Senior Stock Strategist Kevin Cook reveals 7 carefully selected stocks poised to dominate the quantum computing landscape in his report, Beyond AI: The Quantum Leap in Computing Power.Kevin was among the early experts who recognized NVIDIA's enormous potential back in 2016. Now, he has keyed in on what could be "the next big thing" in quantum computing supremacy. Today, you have a rare chance to position your portfolio at the forefront of this opportunity.See Top Quantum Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Zimmer Biomet Holdings, Inc. (ZBH): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: Zimmer Biomet und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!
Ausgewählte Hebelprodukte auf Biomet
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Biomet
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Zimmer Biomet
Analysen zu Zimmer Biomet
Datum | Rating | Analyst | |
---|---|---|---|
30.07.2019 | Zimmer Biomet Equal Weight | Barclays Capital | |
24.04.2019 | Zimmer Biomet Strong Buy | Needham & Company, LLC | |
03.01.2019 | Zimmer Biomet Hold | Deutsche Bank AG | |
16.10.2018 | Zimmer Biomet Underweight | Barclays Capital | |
16.08.2018 | Zimmer Biomet Neutral | BTIG Research |
Datum | Rating | Analyst | |
---|---|---|---|
24.04.2019 | Zimmer Biomet Strong Buy | Needham & Company, LLC | |
13.08.2018 | Zimmer Biomet Buy | Needham & Company, LLC | |
30.07.2018 | Zimmer Biomet Strong Buy | Needham & Company, LLC | |
27.04.2018 | Zimmer Biomet Strong Buy | Needham & Company, LLC | |
31.01.2018 | Zimmer Biomet Buy | Stifel, Nicolaus & Co., Inc. |
Datum | Rating | Analyst | |
---|---|---|---|
30.07.2019 | Zimmer Biomet Equal Weight | Barclays Capital | |
03.01.2019 | Zimmer Biomet Hold | Deutsche Bank AG | |
16.08.2018 | Zimmer Biomet Neutral | BTIG Research | |
30.06.2017 | Zimmer Biomet Neutral | Cantor Fitzgerald | |
04.03.2016 | Zimmer Hold | Argus Research Company |
Datum | Rating | Analyst | |
---|---|---|---|
16.10.2018 | Zimmer Biomet Underweight | Barclays Capital | |
05.10.2011 | Zimmer sell | Citigroup Corp. | |
24.07.2008 | Zimmer Holdings underperform | Credit Suisse Group | |
08.11.2007 | Zimmer Holdings underperform | Credit Suisse Group | |
28.09.2005 | Update Zimmer Holdings Inc.: Market Underperform | JMP Securities |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Zimmer Biomet nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen